International Impact of COVID-19 on the Diagnosis of Heart Disease
Andrew J Einstein, Leslee J Shaw, Cole Hirschfeld, Michelle C Williams, Todd C Villines, Nathan Better, Joao V Vitola, Rodrigo Cerci, Sharmila Dorbala, Paolo Raggi, Andrew D Choi, Bin Lu, Valentin Sinitsyn, Vladimir Sergienko, Takashi Kudo, Bjarne Linde Norgaard, Pal Maurovich-Horvat, Roxana Campisi, Elisa Milan, Lizette Louw Show all
Journal of the American College of Cardiology | ELSEVIER SCIENCE INC | Published : 2021
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. OBJECTIVES: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March a..View full abstract
Dr. Einstein has received consulting fees from W.L. Gore and Associates; has received institutional grant support from Canon Medical Systems, GE Healthcare, Roche Medical Systems, W.L. Gore and Associates, and XyloCor Therapeutics; and has received travel/accommodations/meeting expenses from HeartFlow. Dr. Dorbala has received honoraria from Pfizer and GE Healthcare; and has received institutional research grant support from Pfizer and GE Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.